Cidara Therapeutics (CDTX) Stock Chart & Stock Price History $62.90 -0.41 (-0.65%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$60.00 -2.90 (-4.61%) As of 08/1/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cidara Therapeutics Stock Price Performance The Cidara Therapeutics (CDTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 430.80%, with a year-to-date return of 134.00%. In the past month, the stock has increased 31.60%, reflecting recent market activity. As of the latest close, Cidara Therapeutics traded at $62.90 with a market cap of $1.27 billion and volume of 302,038 shares. Five years ago, the stock traded at a split-adjusted price of $72.20, representing a 12.88% decrease over that period. At the time, it had a market cap of $148.44 million and a volume of 7,627 shares. Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.57%1 Month Performance+31.60%3 Month Performance+190.00%Year-To-Date Performance+134.00%1 Year Performance+430.80%5 Year Performance-12.88% CDTX Stock Chart for Sunday, August, 3, 2025 CDTX Chart by TradingView Cidara Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$63.31$62.90-0.65%$64.25$61.90302,038 shs$1.27 billion07/31/2025$61.79$63.31+2.46%$64.95$61.43362,309 shs$1.28 billion07/30/2025$61.93$61.79-0.23%$63.88$61.19293,546 shs$1.25 billion07/29/2025$62.68$61.93-1.20%$63.17$61.02204,682 shs$1.25 billion07/28/2025$61.85$62.68+1.34%$63.20$60.71286,352 shs$1.26 billion07/25/2025$62.82$61.85-1.54%$63.84$60.73360,352 shs$1.25 billion07/24/2025$64.85$62.82-3.13%$65.24$62.00656,732 shs$1.27 billion07/23/2025$61.53$64.85+5.40%$66.95$61.00837,812 shs$1.31 billion07/22/2025$57.05$61.53+7.85%$62.16$54.91694,458 shs$1.24 billion07/21/2025$59.96$57.05-4.85%$60.38$56.17912,674 shs$1.15 billion Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$56.15$59.96+6.79%$61.60$54.521.11 million shs$1.21 billion07/17/2025$52.26$56.15+7.44%$56.49$51.69584,298 shs$1.13 billion07/16/2025$51.49$52.26+1.50%$52.53$50.25437,115 shs$1.05 billion07/15/2025$55.32$51.49-6.92%$55.31$50.94701,554 shs$1.04 billion07/14/2025$50.53$55.32+9.48%$55.75$49.431.34 million shs$1.12 billion07/11/2025$50.88$50.53-0.69%$52.50$48.37496,771 shs$1.02 billion07/10/2025$50.96$50.88-0.16%$52.31$49.31458,434 shs$1.03 billion07/09/2025$50.45$50.96+1.01%$52.33$47.691.25 million shs$1.03 billion07/08/2025$48.30$50.45+4.45%$50.66$45.871.17 million shs$1.02 billion07/07/2025$47.80$48.30+1.06%$48.52$45.59764,562 shs$973.73 million07/04/2025$47.80$47.80$49.37$46.39412,729 shs$963.55 million07/03/2025$47.87$47.80-0.16%$49.37$46.39412,729 shs$583.58 million07/02/2025$49.03$47.87-2.37%$48.76$44.461.16 million shs$584.49 million Related Companies Axsome Therapeutics Stock Chart Telix Pharmaceuticals Stock Chart Vaxcyte Stock Chart Merus Stock Chart Cytokinetics Stock Chart Avidity Biosciences Stock Chart ADMA Biologics Stock Chart Krystal Biotech Stock Chart Metsera Stock Chart Abivax Stock Chart Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDTX) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
